D. E. Shaw & Co., Inc. Kamada LTD Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding KMDA
# of Institutions
31Shares Held
6.24MCall Options Held
200Put Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.83MShares$15.3 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$11.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny856KShares$7.13 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA630KShares$5.25 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3499KShares$4.16 Million0.27% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $373M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...